Product image of Onsetrogen Mylan (Ondansetron) supplied by GNH India

Onsetrogen Mylan

Active Ingredient:
Ondansetron
Origin:
EU

Onsetrogen Mylan (Ondansetron)

Ondansetron, the active ingredient in Onsetrogen Mylan, is a serotonin 5‑HT3 receptor antagonist presented as an oral dosage form for systemic use. It is employed to prevent and treat nausea and vomiting associated with chemotherapy, radiation therapy, surgery, and pregnancy.

GNH India supplies Onsetrogen Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution. Clients benefit from consistent product availability and comprehensive regulatory support.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron acts on the serotonergic pathway to control nausea and vomiting.

  • Chemotherapy‑induced nausea and vomiting: prevents and treats nausea and vomiting caused by cytotoxic chemotherapy.
  • Postoperative nausea and vomiting: reduces incidence of nausea and vomiting after surgical procedures.
  • Radiotherapy‑induced nausea and vomiting: controls nausea and vomiting associated with cancer radiation treatment.
  • Pregnancy‑related nausea and vomiting (off‑label): may be used to manage severe nausea and vomiting during pregnancy when other therapies are ineffective.

How It Works

  • Ondansetron selectively blocks peripheral and central 5‑HT3 receptors, which are ligand‑gated ion channels activated by serotonin released in the gastrointestinal tract and the chemoreceptor trigger zone. By inhibiting these receptors, the drug prevents the initiation of the vomiting reflex cascade triggered by chemotherapeutic agents, radiation, surgical stimuli, or hormonal changes in pregnancy.

Side Effects

Ondansetron may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Dizziness: transient light‑headedness.
  • Fatigue: feeling of tiredness.
  • Diarrhoea: loose stools.
  • Dry mouth: reduced salivation.

Serious or Rare Side Effects

  • QT interval prolongation: may lead to cardiac arrhythmias.
  • Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity when combined with other serotonergic agents.
  • Cardiac arrhythmia: irregular heart rhythm beyond QT prolongation.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

When prescribing ondansetron, clinicians should consider several precautionary measures to ensure safe use.

  • Cardiac assessment: evaluate QT interval and correct electrolyte abnormalities before use.
  • Hepatic function: adjust dosing in patients with severe liver impairment.
  • Renal function: monitor in patients with renal failure.
  • Hypersensitivity: discontinue if an allergic reaction occurs.
  • Drug interactions: review concomitant medications that may prolong QT.
  • Store below 25°C: keep in the original container, protect from moisture.

Avoid Interactions

Ondansetron can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Apomorphine: concurrent use may cause severe hypotension and loss of consciousness.
  • Other QT‑prolonging agents (e.g., quinidine, haloperidol): increase risk of cardiac arrhythmias.
  • Serotonergic drugs (e.g., SSRIs, MAO inhibitors): risk of serotonin syndrome.
  • Carbamazepine: induces metabolism, reducing ondansetron levels.

Moderate Interactions (Monitor Closely)

  • Dexamethasone: may enhance antiemetic effect, monitor for additive side effects.
  • Cyclophosphamide: may increase ondansetron plasma concentration.
  • Anesthetic agents (e.g., propofol): monitor for additive sedation.
  • Anticholinergic antiemetics: may alter efficacy.

Frequently Asked Questions

Onsetrogen Mylan contains ondansetron, an antiemetic indicated to prevent and treat nausea and vomiting that result from chemotherapy, radiation therapy, surgical procedures, and, in some cases, pregnancy‑related severe nausea.

Ondansetron works by selectively blocking serotonin (5‑HT3) receptors located in the gastrointestinal tract and the brain’s chemoreceptor trigger zone. This blockade stops serotonin‑mediated signaling that initiates the vomiting reflex.

The specific dose of ondansetron is determined by the prescribing clinician based on the patient’s condition, age, and treatment protocol. Dosage regimens differ for chemotherapy, postoperative care, and other indications, and should follow the prescriber’s instructions.

Ondansetron is classified as a pregnancy category that varies by region; it may be used when the potential benefit outweighs the risk. Limited data exist for breastfeeding, and clinicians should assess the risk‑benefit ratio before prescribing to nursing mothers.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ondansetron belongs to the 5‑HT3 antagonist class, offering rapid onset and effectiveness against chemotherapy‑induced and postoperative nausea. Compared with dopamine antagonists or antihistamines, it has fewer sedative effects but requires attention to cardiac QT prolongation and drug‑interaction potential.

Store the product below 25 °C in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and avoid exposure to high humidity or temperature extremes to maintain product stability.

Onsetrogen Mylan is administered orally, typically as a tablet or oral solution. It should be taken with or without food as directed by the prescriber, and the exact timing relative to chemotherapy or surgery is determined by the treating physician.

Serious risks include QT interval prolongation leading to potentially life‑threatening arrhythmias, severe allergic reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic agents. Patients should be monitored for cardiac symptoms, rash, or signs of excessive serotonin activity.

Ondansetron should be avoided in individuals with known hypersensitivity to the drug or any 5‑HT3 antagonist, in patients with congenital long QT syndrome, and in those taking medications that significantly prolong the QT interval unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT